Abstract
Type I DNA topoisomerases are ubiquitous enzymes involved in many aspects of DNA metabolism. Escherichia coli possesses two type I topoisomerase activities, DNA topoisomerase I (Topo I) and III (Topo III). The gene encoding Topo III (topB) can be deleted without affecting cell viability. Cells possessing a deletion of the gene encoding Topo I (topA) are only viable in the presence of an additional compensatory mutation. In the presence of compensatory mutations, Topo I deletion strains grow normally; however, if Topo III activity is repressed in these cells, they filament extensively and possess an abnormal nucleoid structure. These defects can be suppressed by the deletion of the recA gene, suggesting that these enzymes may be involved in RecA-mediated recombination and may specifically resolve recombination intermediates before partitioning.
The requirement for topoisomerases during replication has been observed in all organisms. DNA topoisomerases fall into two classes: type I and type II. In Escherichia coli, type II topoisomerases [DNA gyrase (1) and topoisomerase IV (Topo IV) (2)] are involved in many DNA metabolic processes, among which are decatenation (Topo IV) and the maintenance of superhelical density within the cell (DNA gyrase) (for a review see ref. 3).
There are also two type I topoisomerases in E. coli, topoisomerase I (Topo I), encoded by topA (4, 5), and topoisomerase III (Topo III), encoded by topB (6–9). Genetic studies of topA deletion strains of E. coli showed that these strains are viable only because they acquire a secondary compensatory mutation. In the topA deletion strains DM750 and DM800, these mutations have been mapped to the gyrA and gyrB genes, respectively (10, 11). These mutant alleles compensate for the loss of Topo I by encoding DNA gyrase subunits with diminished supercoiling activity (12, 13). This adaptation appears to be in response to the chromosome accumulating excess negative supercoils in the absence of Topo I activity. One consequence of the accumulation of the excess supercoils appears to be R-loop formation, which can inhibit cell growth (14, 15). This evidence suggests that the major function of Topo I in vivo may be in the regulation of superhelical density. Cells lacking Topo I activity, which have acquired compensatory mutations, grow normally, and no gross chromosomal segregation defects have been identified.
Topo III is extremely efficient in the decatenation of gapped, multiply interlinked DNA dimers and DNA replication intermediates in vitro. Based on this observation, it has been proposed that Topo III may play a role in chromosomal segregation (8). In addition, Topo III, in conjunction with the RecQ helicase, is capable of decatenating completely double-stranded interlinked DNA molecules (16), presumably via two sequential strand passage reactions. Previously, the decatenation of completely double-stranded interlinked circular DNA molecules was ascribed solely to type II topoisomerases. This observation has led to further speculation that type I topoisomerases may be involved in the segregation of nascent chromosomes.
Strains lacking topB exhibit a RecA-independent hyperrecombination phenotype between small direct repeated sequences (17). Interestingly, topA deletion strains also exhibit a similar phenotype (18) although it is unclear whether the two enzymes are involved in overlapping or distinct pathways. This suggests that type I topoisomerases also could be involved in the suppression of RecA-independent illegitimate recombination.
Although topB mutants in E. coli exhibit a hyperrecombination phenotype (17), they are viable and do not appear to acquire compensatory mutations (9). A possible explanation for this observation is that Topo I and Topo III may have partially overlapping activities. Consistent with this hypothesis, studies have indicated that E. coli topA deletion strains DM750 and DM800 resist chromosomal disruption of the topB gene (19). Although it is clear that Topo I plays a role in the maintenance of the superhelical density of chromosomal DNA in the cell, it is still unclear what role, if any, Topo III or type I topoisomerases in general play in chromosomal decatenation or recombination. In an effort to further define the role of E. coli type I topoisomerases in DNA metabolism, we have characterized the effect of repressing both type I topoisomerase activities in E. coli. Cells lacking both topoisomerase activities filament extensively and do not appear to segregate chromosomal DNA. The phenotype of these cells is not suppressed by the expression of the potent decatenating enzyme Topo IV; however, deletion of the recA gene suppresses this phenotype, suggesting that Topo I and Topo III may have a significant role in RecA-mediated DNA recombination rather than decatenation.
Materials and Methods
Bacterial Strains.
The E. coli (K-12) strains used in this work are listed in Table 1 and Table 2, which is published as supplemental material on the PNAS web site, www.pnas.org.
Table 1.
Strains | Genotype | Source or reference |
---|---|---|
MG1655 | F−, λ− | Coli Genetic Stock Center |
TP606 | sulA6209 (cotransducible with tetr) | 33 |
DM4100 | cysB am242 | 10, 11 |
DM750 | Δ(cysB topA)218 acrA12 gyrA224 | 10, 11 |
DM800 | Δ(cysB topA)204 acrA13 gyrB225 | 10, 11 |
GD504 | MG1655 lexA3∷malTn10 | M. Drolet |
MA972 | RFM443 ΔrecA306 srlR301∷Tn10 | M. Drolet |
QZ101 | DM4100/pDE1 | This work |
QZ102 | DM4100 ΔtopB∷ aphA/pDE1 | This work |
QZ103 | MG1655 ΔtopB∷ aphA | P1:QZ102 × MG1655, kanr |
QZ104 | DM750/pTBE302 | This work |
QZ105 | DM750/pTBE33 | This work |
QZ106 | DM750 ΔtopB∷ aphA/pTBE302 | P1:QZ103 × QZ104, kanr |
QZ107 | DM750 ΔtopB∷ aphA/pTBE302/pLex5BA-parEC | This work |
QZ108 | DM750/pTBE302/pMAYrecA | This work |
QZ109 | DM750 ΔrecA306 srlR301∷Tn10/pTBE302/pMAYrecA | P1:MA972 × QZ107, tetr |
QZ110 | DM750 ΔrecA306 srlR301∷Tn10 ΔtopB∷ aphA/pTBE302/pMAYrecA | P1:QZ103 × QZ108, kanr tetr |
QZ111 | DM750 ΔrecA306 srlR301∷Tn10 ΔtopB∷aphA/pTBE302 | This work |
QZ112 | DM750 ΔtopB∷aphA lexA3∷malTn10/pTBE302 | P1:GD504 × QZ106, tetr |
QZ113 | DM750 ΔtopB∷aphA sulA6209/pTBE302 | P1:TP606 × QZ106, kanr tetr |
The genotypes and source of the E. coli strains used in this study are indicated. In the case of P1 transductions, relevant antibiotic selection markers also are provided.
Microbiological Techniques.
Expression of the topB gene was studied by using minimal M9 medium supplemented with 0.25% casamino acids, 0.2% glycerol, and 0.005% arabinose or glucose. The cultures were grown at 37°C overnight in M9 medium containing arabinose. The overnight culture was diluted to OD600 = 0.01 into arabinose or glucose containing medium. The growth rates of cultures were determined by measuring the cell density at various times. Viable cell count was determined by plating on M9 agar medium supplemented with 0.25% casamino acids and 0.005% arabinose or glucose and incubated overnight at 37°C.
The bacterial strain DH5-α, which was used to prepare all plasmid DNAs, was prepared by CaCl2 treatment (20) and used for transformation. Antibiotics, when required, were at the following concentrations: ampicillin, 100 μg/ml; chloramphenicol, 30 μg/ml, kanamycin, 30 μg/ml.
P1 Transduction, Strain, and Plasmid Construction.
Phage P1vir was grown on host strains carrying different antibiotic-resistant markers and used to transduce mutations into strains by using the method described by Miller (21). A complete topB deletion was constructed by amplifying 1,000 bp upstream and downstream of topB by PCR. A kanamycin-resistance cassette (aphA) then was inserted between the two regions, generating a complete deletion of the topB gene within a pMAK705 vector (pBK1). The procedure of Hamilton et al. (22) was then used to create the gene deletion in the E. coli strain DM4100, containing topB expression plasmid pDE1 (QZ101) (9). The expression plasmid was used in case deletion of the topB gene was detrimental to cell growth. Strain DM4100 ΔtopB harboring plasmid pDE1(QZ102) was then used to generate a P1 transducing phage stock and to transduce a wild-type strain MG1655 to ΔtopB (QZ103).
Construction of the recA deletions was accomplished by using pMAYrecA (provided by T. Hill, University of North Dakota). This plasmid contains the recA gene on a pMAK705 plasmid (22). Cells harboring pMAYrecA were transduced to ΔrecA at 30°C and then the cells were cured of the plasmid by incubating the cells at 42oC (pMAK705 contains a temperature-sensitive replicon).
To achieve physiologically appropriate levels of Topo III expression, highly regulated transient expression plasmids were used to create expression plasmids pTBE302 and pTBE33. These pBAD plasmids contain the PBAD promoter of the araBAD (arabinose) operon, the PBAD regulatory gene araC, and a relatively low copy number plasmid pACYC origin (23). Plasmid pBAD33 contains the chloromphenicol-resistant (catr) gene, whereas pBAD30 contains the ampicillin-resistance (ampr) marker. The topB gene sequence was excised from the pET topB expression plasmid pL-1 at NdeI and EcoRI sites and was filled in by using Klenow fragment (plasmid pL-1 contains an NdeI restriction site within the initiation codon of topB and an EcoRI restriction site immediately downstream of the translational stop codon). The fragment was then ligated into pBAD30 and pBAD33 that were digested and filled in at the XbaI site to create pTBE302 and pTBE33, respectively. This manipulation places the topB gene under the control of a poor Shine–Delgarno sequence within the vectors.
DNA gyrase compensatory mutations were transduced into strains by taking advantage of the fact that the gyrase compensatory mutations are associated with an unusual phenotype, Bgl+ (10). These strains, unlike wild-type strains, are able to constitutively use β-glucosides as a carbon source. Wild-type E. coli K12 strains are Bgl− and are unable to use β-glucosides because the genes of the bgl operon, which are required for catabolism of β-glucosides, are uninducible. Because the Bgl+ phenotype is inseparable from the DNA gyrase compensatory mutations, it has been used to map the compensatory mutations. Screening for Bgl+ was carried out on plates containing 5-bromo-4-chloro-3-indolyl β-d-glucoside (Sigma) at 40 μg/ml. The sugar fermentors (Bgl+) are blue and nonfermentors (Bgl−) are white colonies.
Western Blotting.
Proteins were separated by SDS/PAGE (24) and transferred to a poly(vinylidene difluoride) membrane (Micron Separations, Westboro, MA). Immunodetection was performed with polyclonal antibodies against ParC and ParE as the primary and goat anti-rabbit Ig G conjugated to horseradish peroxidase (New England Biolabs) as the secondary antibody (25). ECL substrate (Amersham Pharmacia) was used to detect the secondary antibody, and the ParC and ParE proteins were visualized by using Kodak X-Omat film.
Fluorescence Microscopy.
A 97-μl aliquot of the cell culture was mixed with 3 μl toluene, incubated at 37°C for 15 min. The mixture was then incubated with 11 μl of 5 μg/ml 4′,6-diamidino-2-phenylindole (DAPI) (Sigma) at room temperature for 5 min. Stained cells (2–3 μl) were spread on slides pretreated with poly-l-lysine (Sigma) and sealed with a cover glass. Fluorescence micrographs were recorded on a Nikon E600 equipped with a ×100 oil immersion objective, a 100-W mercury lamp, and standard DAPI filter sets. Images were captured with a SONY DKC 5000 catseye digital still camera system and processed with Adobe photoshop. Exposures were between 1/50 and 1/15 s for phase-contrast and DAPI images.
Results
The Effect of topB Suppression in topA Deletion Strains.
Although Topo III is not essential for growth and viability, previous studies have shown that it is extremely difficult to disrupt the topB gene in topA deletion strain DM750 unless the strain harbors a plasmid that is capable of expressing topB (19). This finding suggested that at least one type I topoisomerase activity may be required for viability in E. coli. Because Topo III was nonessential for cell growth (9), it seemed possible that Topo I could substitute for Topo III function in vivo. To analyze the effect of the inactivation of type I topoisomerases on DNA metabolism in “real time,” a highly regulated pBAD transient topB expression plasmid (pTBE302) was constructed (23) and used to study the effect of repressing Topo III activity in topA deletion strains. Using this system, Topo III activity can be expressed in the presence of arabinose or repressed in the presence of glucose.
Strain DM750, harboring plasmid pTBE302 (QZ104), was grown in the presence of arabinose, and transduced to ΔtopB∷aphA (QZ106). This strain was then grown overnight in the presence of arabinose and diluted into and grown in M9 medium containing either arabinose or glucose. The cells grown in arabinose-containing medium exhibited a doubling time of about 1 h as assessed by viable cell count (Table 3, which is published as supplemental material). These cells and those of the isogenic parent strain, DM750, grew at a similar rate and possessed similar morphology (Fig. 1, compare CA6 and CG6 with A4, A8, and A14). Cells grown on glucose, however, had a viable cell count that was 6 orders of magnitude lower than the cells grown in arabinose. In addition, these cells became highly filamented over time (Fig. 1 G4, G8, and G14) and were characterized by aberrant nucleoid structures. These data indicated that, at least in this genetic background, it is essential to have at least one type I topoisomerase activity present in the cells and that these enzymes may play a role in chromosome segregation and cell division. Similar results were obtained when E. coli strain DM800 was used in the same experiments (data not shown).
The topA deletion strains DM750 and DM800 contain compensatory mutations in the genes encoding gyrase subunits (gyrA224 in DM750 and gyrB225 in DM800) that allow growth in the absence of Topo I activity (10, 11). It was unclear, therefore, whether the observed phenotype was caused by the repression of both type I topoisomerase activities or the repression of Topo III activity in the presence of gyrase compensatory mutations. To address this issue, the viability of gyrA224 ΔtopB∷aphA and gyrB225 ΔtopB∷aphA mutant strains was assessed (see Table 4, which is published as supplemental material). The presence of either compensatory allele had no effect on the transduction frequency relative to the wild-type strain, indicating that the topB deletion strains were viable in the presence of the gyrase compensatory mutations (Table 4). In addition, the morphology of the cells and nucleoids were identical to the wild-type strain (data not shown). This finding strongly suggests that the observed phenotype was caused by the repression of type I topoisomerase activity in the cells.
A lexA3 or sulA Mutation Cannot Suppress the Growth Defect Phenotype of ΔtopA ΔtopB Cells.
During normal cell growth, the LexA repressor of E. coli represses a set of genes called the SOS regulon (26). When DNA is damaged or replication is inhibited, RecA promotes the cleavage of the LexA repressor by inducing a specific proteolytic cleavage near the center of the repressor, resulting in induction of genes involved in the SOS response. This response helps organisms survive the lethal effect of DNA damage by combining increased expression of genes involved in excision, recombination, and mutagenic repair mechanisms with control of cell division exerted through sulA (sfiA), which delays cell division while repair is affected and causes cell filamentation (26).
Cells are highly filamented in the absence of both type I topoisomerase activities, suggesting that the SOS response may be responsible for the filamentation observed in the ΔtopA ΔtopB mutant strains. To assess this hypothesis, we transduced the lexA3 mutation into DM750 cells. The lexA3 allele encodes a noncleavable repressor protein so that the SOS response cannot be induced. DM750 ΔtopB cells, carrying plasmid pTBE302, were transduced to lexA3 (QZ112). The morphology of these cells and the state of the chromosomes, grown in the presence of glucose and arabinose, were then observed by using fluorescence microscopy (Fig. 2). In comparison to its SOS-inducible parent strain, neither the morphology nor the state of intracellular chromosomes of these lexA3 mutant cells were found to have changed (i.e., they were still highly filamented and exhibited a segregation defect). In addition, DM750 ΔtopB, harboring plasmid pTBE302, was transduced to ΔsulA (QZ113). These cells also filamented in the absence of type I topoisomerase activity (Fig. 2), suggesting that filamentation phenotype of DM750 ΔtopB cells was not caused by SOS induction.
The Chromosomal Segregation Defect of ΔtopA ΔtopB Cells Is Not Caused by a Defect in Decatenation but by a Defect in Recombination.
Evidence, in vitro, has shown that Topo III is a potent decatenase (8). Therefore, it was possible that the abnormal nucleoid morphology in cells lacking type I topoisomerase activity may have been caused by the presence of catenated bacterial chromosomes. Topo IV plays a primary role in decatenating newly replicated daughter chromosomes in E. coli (27). To investigate whether the nature of the aberrant nucleoid morphology in cells lacking type I topoisomerase activity was caused by the accumulation of catenated chromosomes, we examined whether the overexpression of Topo IV could suppress the phenotype of these mutants. An isopropyl β-d-thiogalactoside (IPTG)-inducible Topo IV expression plasmid, plex5BA-parEC (25), was used to increase Topo IV activity within the cells. Plasmid plex5BA-parEC was introduced into DM750 ΔtopB containing plasmid pTBE33 (QZ107), a topB expression plasmid compatible with plex5BA-parEC. Cells were grown in the presence of arabinose, washed, and then diluted into medium containing glucose and IPTG. Overexpression of Topo IV activity was unable to rescue the growth deficient phenotype (Fig. 3), indicating that decatenation activity of Topo IV could not suppress the mutant phenotype (this finding also was confirmed in DM800, data not shown). The same result also was observed if Topo IV activity was induced before repression of Topo III activity (data not shown).
It has been observed that topB deletion strains exhibit an increased RecA-independent recombination frequency between small direct repeats; therefore, Topo III is responsible, either directly or indirectly, for the suppression of illegitimate recombination in these strains. If this is the case, Topo III may be involved in the resolution of recombination intermediates. Failure to resolve such intermediates would lead to an increase in the recombination frequency in the cell. Because the recA gene is essential to all of the homologous recombination pathways in the bacterial cell, we tested this hypothesis by introducing a recA gene deletion into the chromosome of DM750 cells containing plasmid pTBE302. DM750 ΔrecA cells, harboring pTBE302, then were transduced to ΔtopB∷aphA (in the presence of arabinose), and the strain (QZ111) was then analyzed for viability and morphology in the presence of arabinose or glucose. As previously described, the DM750 ΔtopB cells (harboring plasmid pTBE302 (QZ106)) form no colonies in the presence of glucose at 37°C, but DM750 ΔtopB ΔrecA (QZ111) forms colonies in the presence of either glucose or arabinose. These cells, observed by DAPI staining, exhibited regularly spaced nucleoids similar to those observed in the parent strain in the presence of glucose or arabinose (Fig. 4). Interestingly, although the chromosomal segregation defect was completely suppressed in these cells, filamentation was only partially suppressed. Although cells exhibited normal morphology during log-phase growth, the cells became slightly filamented after entry into stationary phase. The same phenotype was observed by using DM800 ΔtopB ΔrecA cells in a similar experiment (data not shown).
Discussion
A highly regulated topB expression, plasmid pTBE302, was introduced into topA deletion strains to study the effect of the repression of type I topoisomerase activity in real time. The repression of Topo III activity in these strains was deleterious to cell growth and caused the cell to filament. Filamentation was also accompanied by abnormal nucleoid structures in which the DNA was strewn throughout the filament, suggesting that type I topoisomerases may be involved in some aspect of chromosomal segregation. Mutations that suppress SOS-induced filamentation, lexA3 and ΔsulA, do not affect the nucleoid abnormalities or filamentation exhibited by ΔtopA ΔtopB cells. This finding does not rule out the possibility that SOS is induced in these cells; however, the defects observed in these cells are clearly not a result of SOS induction.
The phenotype of ΔtopA ΔtopB cells is not associated with the presence of compensatory mutations that are present in topA deletion strains (10, 11). A topB deletion was easily transduced into strains that contained only the gyrase compensatory mutations. The cells grew normally and possessed normal morphology, suggesting that the chromosomal segregation defects observed upon the repression of type I topoisomerase activity are caused solely by the absence of these enzymatic activities and are not related to the presence of any other mutations.
The defect in chromosomal segregation observed in ΔtopA ΔtopB mutants was not caused by a defect in chromosomal decatenation because overexpression of Topo IV, a potent decatenase, did not suppress the phenotype of the ΔtopA ΔtopB mutants. The segregation defect of ΔtopA ΔtopB cells was, however, suppressed by the deletion of the recA gene. The ΔtopA ΔtopB ΔrecA cells exhibit distinct nucleoids regardless of the expression of Topo III, suggesting that type I topoisomerases are primarily involved in recombination as opposed to being directly involved in chromosomal decatenation. Interestingly, although ΔtopA ΔtopB ΔrecA cells have isolated and distinct nucleoids, they still filament slightly during stationary phase. This phenomenon is also independent of the SOS response because ΔrecA cells are incapable of SOS induction.
An essential question is what step in recombination could be affected by type I topoisomerases? Whether or not recombination is legitimate or illegitimate, a Holliday junction is formed between the two participating molecules. During this process, two independent DNA molecules are covalently linked via the junction. If DNA replication occurs in molecules undergoing recombination, torsional stress could be transferred to the recombination junction, resulting in the accumulation of interlinks between the homologous strands engaged in the exchange (Fig. 5). The presence of a topoisomerase with a preference for binding single-strand DNA could play a role in the unlinking of this intermediate and generate an “open” structure that could be recognized by the Holliday junction resolvase. This model predicts that mutations that affect events before strand incision (recA and recBCD mutations) should suppress the chromosomal segregation defect observed in cells lacking type I topoisomerase activity. Mutations that affect events after Holliday junction formation (recG, ruvABC), on the other hand, should not suppress the segregation defect.
It recently has been shown that yeast Topo III interacts with the Sgs1 helicase (28, 29). The Sgs1 helicase is a member of the RecQ family of helicases. In addition, E. coli Topo III and RecQ protein also appear to act synergistically with one another, creating a very efficient catenation activity (16). It is tempting to hypothesize that E. coli type I topoisomerases and helicases, similar to what has been proposed for eukaryotes (30- 32), are capable of interacting to form a “toposome” that is capable of acting as an unwinding machine. In support of this hypothesis, have we recently found that ΔtopA ΔrecQ mutants exhibit a phenotype identical to ΔtopA ΔtopB mutants (Q.Z. and R.J.D., unpublished work). Therefore, a toposome could be essential to resolving recombination intermediates before chromosome partitioning in both prokaryotes and eukaryotes.
Supplementary Material
Acknowledgments
We thank Drs. A. Wilks and K. Marians for critical reading of this manuscript. These studies were supported by Grant GM48445 from the National Institutes of Health (to R.J.D.).
Abbreviations
- Topo I
topoisomerase I
- Topo III
topoisomerase III
- Topo IV
topoisomerase IV
- DAPI
4′,6-diamidino-2-phenylindole
- IPTG
isopropyl β-d-thiogalactoside
Footnotes
This paper was submitted directly (Track II) to the PNAS office.
References
- 1.Gellert M, Mizuuchi K, O'Dea M, Nash H. Proc Natl Acad Sci USA. 1976;73:3872–3876. doi: 10.1073/pnas.73.11.3872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kato J-I, Nishimura Y, Imamura R, Niki H, Hiraga S, Suzuki H. Cell. 1990;63:3967–3977. doi: 10.1016/0092-8674(90)90172-b. [DOI] [PubMed] [Google Scholar]
- 3.Wang J C. Annu Rev Biochem. 1996;65:635–692. doi: 10.1146/annurev.bi.65.070196.003223. [DOI] [PubMed] [Google Scholar]
- 4.Wang J C. J Mol Biol. 1971;55:523–533. doi: 10.1016/0022-2836(71)90334-2. [DOI] [PubMed] [Google Scholar]
- 5.Tse-Dinh Y C, Wang J C. J Mol Biol. 1986;191:321–331. doi: 10.1016/0022-2836(86)90129-4. [DOI] [PubMed] [Google Scholar]
- 6.Pastorcic M. Ph.D. Thesis. Chicago: The University of Chicago; 1982. [Google Scholar]
- 7.Srivenugopal K S, Lockshon D, Morris D R. Biochemistry. 1984;23:1899–1906. doi: 10.1021/bi00304a002. [DOI] [PubMed] [Google Scholar]
- 8.DiGate R J, Marians K J. J Biol Chem. 1988;263:13366–13373. [PubMed] [Google Scholar]
- 9.DiGate R J, Marians K J. J Biol Chem. 1989;264:17924–17930. [PubMed] [Google Scholar]
- 10.DiNardo S, Voelkel K A, Sternglanz R, Reynolds A E, Wright A. Cell. 1982;31:43–51. doi: 10.1016/0092-8674(82)90403-2. [DOI] [PubMed] [Google Scholar]
- 11.Pruss G J, Manes S H, Drlica K. Cell. 1982;31:35–42. doi: 10.1016/0092-8674(82)90402-0. [DOI] [PubMed] [Google Scholar]
- 12.McEachern F, Fisher L M. FEBS Lett. 1989;253:67–70. doi: 10.1016/0014-5793(89)80931-7. [DOI] [PubMed] [Google Scholar]
- 13.Oram M, Fisher L M. J Bacteriol. 1992;174:4175–4178. doi: 10.1128/jb.174.12.4175-4178.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Drolet M, Phoenix P, Menzel R, Masse E, Liu L F, Crouch R J. Proc Natl Acad Sci USA. 1995;92:3526–3530. doi: 10.1073/pnas.92.8.3526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Masse E, Drolet M. J Biol Chem. 1999;274:16659–16664. doi: 10.1074/jbc.274.23.16659. [DOI] [PubMed] [Google Scholar]
- 16.Harmon F G, DiGate R J, Kowalcykowski S C. Mol Cell. 1999;3:611–620. doi: 10.1016/s1097-2765(00)80354-8. [DOI] [PubMed] [Google Scholar]
- 17.Schofield M A, Agbung R, Michaels M L, Miller J H. J Bacteriol. 1992;174:5168–5170. doi: 10.1128/jb.174.15.5168-5170.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Reddy M, Gowrishankar J. J Bacteriol. 2000;182:1978–1086. doi: 10.1128/jb.182.7.1978-1986.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Li Z Y, Hiasa H, Kumar U, DiGate R J. J Biol Chem. 1997;272:19582–19587. doi: 10.1074/jbc.272.31.19582. [DOI] [PubMed] [Google Scholar]
- 20.Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Plainview, NY: Cold Spring Harbor Lab. Press; 1989. [Google Scholar]
- 21.Miller J H. A Short Course in Bacterial Genetics. Plainview, NY: Cold Spring Harbor Lab. Press; 1992. [Google Scholar]
- 22.Hamilton C M, Aldea M, Washburn B K, Babitzke P, Kushner S R. J Bacteriol. 1989;171:4617–4622. doi: 10.1128/jb.171.9.4617-4622.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Guzman L M, Belin D, Carson M J, Beckwith J. J Bacteriol. 1995;177:4121–4130. doi: 10.1128/jb.177.14.4121-4130.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Laemmli U K. Nature (London) 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- 25.Mossessova E, Levine C, Peng H, Nurse P, Bahng S, Marians K J. J Biol Chem. 2000;275:4099–4103. doi: 10.1074/jbc.275.6.4099. [DOI] [PubMed] [Google Scholar]
- 26.Humayun M Z. Mol Microbiol. 1998;30:905–910. doi: 10.1046/j.1365-2958.1998.01120.x. [DOI] [PubMed] [Google Scholar]
- 27.Adams D E, Shekhtman E M, Zechiedrich E L, Schmid M B, Cozzarelli N R. Cell. 1992;71:277–288. doi: 10.1016/0092-8674(92)90356-h. [DOI] [PubMed] [Google Scholar]
- 28.Gangloff S, McDonald J P, Bendixen C, Arthur L, Rothstein R. Mol Cell Biol. 1994;14:8391–8398. doi: 10.1128/mcb.14.12.8391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bennett R J, Noirot-Gros M F, Wang J C. J Biol Chem. 2000;275:26898–26905. doi: 10.1074/jbc.M003137200. [DOI] [PubMed] [Google Scholar]
- 30.Wang J C. J Biol Chem. 1991;266:6659–6662. [PubMed] [Google Scholar]
- 31.Watt P M, Louis E J, Borts R H, Hickson I D. Cell. 1995;81:253–260. doi: 10.1016/0092-8674(95)90335-6. [DOI] [PubMed] [Google Scholar]
- 32.Rothstein R, Gangloff S. Genome Res. 1995;5:421–426. doi: 10.1101/gr.5.5.421. [DOI] [PubMed] [Google Scholar]
- 33.Poteete A R, Fenton A C. J Bacteriol. 2000;182:2336–2340. doi: 10.1128/jb.182.8.2336-2340.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.